Rocket Pharmaceuticals In...
(RCKT)
undefined
undefined%
At close: undefined
12.02
0.04%
After-hours Dec 13, 2024, 05:19 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 7.10M | 6.27M | 5.37M | 1.15M | 426.00K | 330.00K | 204.00K | 169.00K | 45.00K | - | - | - |
Gross Profit | -7.10M | -6.27M | -5.37M | -1.15M | -426.00K | -330.00K | -204.00K | -169.00K | -45.00K | - | - | - |
Operating Income | -259.66M | -224.34M | -167.25M | -134.30M | -76.15M | -71.16M | -26.74M | -41.88M | -20.40M | -7.70M | -6.65M | -5.85M |
Interest Income | 15.94M | 3.89M | 3.07M | 2.15M | 3.41M | 1.69M | 819.00K | 443.00K | 89.00K | - | - | - |
Pretax Income | -245.59M | -221.86M | -169.07M | -139.70M | -77.27M | -74.52M | -29.50M | -42.85M | -67.98M | -9.53M | -7.62M | -6.06M |
Net Income | -245.59M | -219.38M | -169.59M | -146.67M | -83.23M | -74.52M | -29.50M | -42.85M | -67.98M | -9.53M | -7.62M | -6.06M |
Selling & General & Admin | 73.32M | 58.77M | 41.77M | 27.92M | 17.53M | 17.89M | 12.54M | 9.89M | 7.84M | 2.11M | 1.32M | 2.31M |
Research & Development | 186.34M | 165.57M | 125.48M | 106.38M | 58.62M | 53.27M | 14.19M | 31.98M | 12.55M | 5.59M | 5.33M | 3.54M |
Other Expenses | - | -500.00K | -1.00M | - | -250.00K | 186.00K | - | - | - | - | 3.00K | 4.00K |
Operating Expenses | 259.66M | 223.84M | 166.25M | 134.30M | 75.90M | 70.97M | 26.74M | 41.88M | 20.40M | 7.70M | 6.65M | 5.85M |
Interest Expense | 1.88M | 1.91M | 5.89M | 7.55M | 4.78M | 5.24M | 3.58M | 1.42M | 1.23M | 980.00K | 884.00K | 213.00K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 259.66M | 223.84M | 166.25M | 134.30M | 75.90M | 70.97M | 26.74M | 41.88M | 20.40M | 7.70M | 6.65M | 5.85M |
Income Tax | - | -2.48M | 516.00K | 6.97M | 5.96M | 2.68M | 819.00K | 443.00K | 1.23M | - | 884.00K | 217.00K |
Shares Outstanding (Basic) | 84.01M | 68.15M | 63.24M | 55.38M | 49.01M | 39.38M | 6.77M | 6.68M | 4.58M | 3.42M | 2.10M | 2.10M |
Shares Outstanding (Diluted) | 84.01M | 68.15M | 63.24M | 55.38M | 49.01M | 39.38M | 6.77M | 6.68M | 4.58M | 3.42M | 2.10M | 2.10M |
EPS (Basic) | -2.92 | -3.22 | -2.68 | -2.65 | -1.7 | -1.89 | -4.36 | -6.41 | -14.85 | -2.79 | -3.62 | -2.88 |
EPS (Diluted) | -2.92 | -3.22 | -2.68 | -2.65 | -1.7 | -1.89 | -4.36 | -6.41 | -14.85 | -2.79 | -3.62 | -2.88 |
EBITDA | -236.62M | -213.69M | -161.72M | -131.59M | -71.14M | -71.16M | -26.74M | -41.27M | -20.26M | -7.70M | -6.73M | -5.84M |
Depreciation & Amortization | 7.10M | 6.27M | 5.37M | 1.15M | 426.00K | 330.00K | 204.00K | 169.00K | 45.00K | - | 3.00K | 9.00K |